Effect of SSRIs on Response to Psilocybin Therapy

NCT05594667 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped Funding

Conditions

Depression
Major Depressive Disorder
Mild Depression
Moderate Depression
Depressive Disorder

Interventions

DRUG: Psilocybin

Sponsor

Cybin Therapeutics Inc.